|
MFSD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.140670E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.463900E-02 |
| Normal-vs-Stage2 |
4.695700E-02 |
| Normal-vs-Stage3 |
4.459600E-01 |
| Normal-vs-Stage4 |
2.288500E-02 |
| Stage1-vs-Stage2 |
1.447160E-01 |
| Stage1-vs-Stage3 |
1.356000E-01 |
| Stage1-vs-Stage4 |
8.658300E-03 |
| Stage2-vs-Stage3 |
2.969800E-02 |
| Stage2-vs-Stage4 |
7.743400E-03 |
| Stage3-vs-Stage4 |
7.083800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.744800E-03 |
| Normal-vs-AfricanAmerican |
1.017840E-01 |
| Normal-vs-Asian |
9.525200E-01 |
| Caucasian-vs-AfricanAmerican |
9.393000E-01 |
| Caucasian-vs-Asian |
5.196800E-01 |
| AfricanAmerican-vs-Asian |
5.540600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.900500E-03 |
| Normal-vs-Female |
4.632400E-02 |
| Male-vs-Female |
9.973600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.005200E-01 |
| Normal-vs-Extreme_Weight |
1.647590E-01 |
| Normal-vs-Obese |
1.019230E-01 |
| Normal-vs-Extreme_Obese |
9.442800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.411000E-01 |
| Normal_Weight-vs-Obese |
5.890800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.831000E-01 |
| Extreme_Weight-vs-Obese |
6.318000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.365200E-01 |
| Obese-vs-Extreme_Obese |
5.235000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.175600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.869900E-02 |
| Normal-vs-Age(61-80Yrs) |
2.744700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.947160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.062400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.454000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.150400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.800000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.909200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.012400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.773000E-04 |
| Normal-VS-Type2 PRCC |
1.410640E-01 |
| Normal-VS-KIRP CIMP |
6.578400E-02 |
| Normal-VS-Unclassified PRCC |
8.637900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.110600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.356500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.511020E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.976400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.592560E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.539300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.852600E-01 |
| Normal-vs-N1 |
1.766640E-01 |
| Normal-vs-N2 |
5.947400E-01 |
| N0-vs-N1 |
1.737020E-01 |
| N0-vs-N2 |
4.640400E-01 |
| N1-vs-N2 |
8.561600E-01 |
|
|
